Treatment of atopic dermatitis eczema with a high concentration of Lactobacillus salivarius LS01 associated with an innovative gelling complex a pilot study on adults

Journal of Clinical Gastroenterology

Volumn 48, Issue , 2014, Pages S47-S51

  Drago, Lorenzo ^a,b   De Vecchi, Elena ^a   Toscano, Marco ^a   Vassena, Christian ^a   Altomare, Gianfranco ^a,b   Pigatto, Paolo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Dermatitis; Lactobacillus salivarius; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT; GEL; PLANT GUM; TARA GUM;

ADULT; ATOPIC DERMATITIS; BACTERIAL COUNT; BACTERIAL STRAIN; CLINICAL ARTICLE; CLOSTRIDIA; CONFERENCE PAPER; CONTROLLED STUDY; FECES MICROFLORA; FEMALE; HUMAN; LACTOBACILLUS SALIVARIUS; MALE; PILOT STUDY; PROSPECTIVE STUDY; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; ADHESION; CLASSIFICATION; DERMATITIS, ATOPIC; FECES; GEL; INTESTINE MUCOSA; ITALY; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; TIME; TREATMENT OUTCOME;

ADHESIVENESS; ADULT; DERMATITIS, ATOPIC; FECES; GELS; HUMANS; INTESTINAL MUCOSA; ITALY; LACTOBACILLUS; PILOT PROJECTS; PLANT GUMS; PROBIOTICS; PROSPECTIVE STUDIES; STREPTOCOCCUS THERMOPHILUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84916598855     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000249     Document Type: Conference Paper

References (40)

1. Denby KS, Beck LA. Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol. 2012;12:421-426.
2. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358: 1483-1494.
3. Wollenberg A, Ehmann LM. Long term treatment concepts and proactive therapy for atopic eczema. Ann Dermatol. 2012;24:253-260.
4. Sánchez-Pérez J, Daudén-Tello E, Mora AM, et al. Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study. Actas Dermosifiliogr. 2013;104:44-52.
5. Gupta MA, Gupta AK. Sleep-wake disorders and dermatology. Clin Dermatol. 2013;31:118-126.
6. Darsow U, Wollenberg A, Simon D, et al. EFTAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24:317-328.
7. Garmhausen D, Hagenmann T, Bieber T, et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy. 2013;68:498-506.
8. Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22:125-137.
9. Caroline R, Frei R, Loss G, et al. Development of atopic dermatitis according to age of onset and association with early life exposure. J Allergy Clin Immunol. 2012;130:130-136.
10. Kodama A, Horkawa T, Suzuki T, et al. Effects of stress on atopic dermatitis: investigation in patients after the great Hanshin earthquake. J Allergy Clin Immunol. 1999;104: 173-176.
11. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441-446.
12. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011; 365:1315-1327.
13. Kabashima K. New concepts of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy and pruritus as a trinity. J Dermatol Sci. 2013;70:3-11.
14. Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62: 151-161.
15. De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junctions defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127:773-786.
16. Jinnestal CL, Belfrage E, Back O, et al. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol. 2014;53:27-33.
17. Suárez-Fariñas M, Dhingra N, Gittler J, et al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132:361-370.
18. Auriemma M, Vianale G, Amerio P, et al. Cytokines and T cells in atopic dermatitis. Eur Cytokine Netw. 2013;24:37-44.
19. Chen YE, Tsao H. The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol. 2013;69:143-155.
20. Kong HH, Oh J, Deming S, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22:850-859.
21. Penders J, Gerhold K, Stobberingh EE, et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol. 2013;132:601-607.
22. Ouwehand AC, Isolauri E, He F, et al. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol. 2001;108:144-145.
23. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56: 661-667.
24. Hwang JS, Im Cr, Im SH. Immune disorders and its correlation with gut microbiome. Immune Netw. 2012;12: 129-138.
25. Silverberg JI. Atopic dermatitis: an evidence-based treatment update. Am J Clin Dermatol. 2014;25:149-164.
26. Foolad N, Armstrong AW. Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children. Benef Microbes. 2014;24:1-10.
27. Han Y, Kim B, Ban J, et al. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr Allergy Immunol. 2012;23:667-673.
28. Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42:1071-1079.
29. van der Aa LB, Heymans HAS, van Aalderen WMV, et al. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol. 2010;21:e355-e367.
30. Drago L, Nicola L, Iemoli E, et al. Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res Notes. 2010;3:44.
31. Drago L, Toscano M, De Vecchi E, et al. Changing of fecal flora and clinical effect of L. Salivarius LS01 in adults with atopic dermatitis. J Clin Gastroenterol. 2012;46:S56-S63.
32. Iemoli E, Trabattoni D, Parisotto S, et al. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol. 2012;46:S33-S40.
33. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;1980:44-47.
34. Jonasson J, Olofsson M, Monstein HJ. Classification, identification and subtyping of bacteria based on pyrosequencing and signature matching of 16s rDNA fragments. APMIS. 2007;15:668-677.
35. Ozdemir O, Goksu Erol AY. Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings. Biomed Res Int. 2013 Sep 1. Doi: 10.1155/ 2013/932391. [Epub ahead of print].
36. Kim HJ, Kim HY, Lee SY, et al. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J Pediatr. 2013;56:369-376.
37. Kim NY, Geun EJ. Effects of probiotics on the prevention of atopic dermatitis. Korean J Pediatr. 2012;55:193-201.
38. Weston S, Halbert A, Richmond P, et al. Effects of probiotics on atopic dermatitis: a randomized controlled trial. Arch Dis Child. 2005;90:892-897.
39. Watanabe S, Narisawa Y, Arase S, et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2003; 111:587-597.
40. Kimata H. Modulation of fecal polyamines by viewing humorous films in patients with atopic dermatitis. Eur J Gastroenterol Hepatol. 2010;22:724-728.